Journal of the American Society of Nephrology, Vol 7, 2176-2182, Copyright © 1996 by American Society of Nephrology

REGULAR ARTICLES

Peritonitis influences mortality in peritoneal dialysis patients

LF Fried, J Bernardini, JR Johnston and B Piraino
Department of Medicine, University of Pittsburgh School of Medicine, PA, USA.

Mortality remains high in peritoneal dialysis (PD) patients. Known risk factors for mortality include age, diabetes, race, initial albumin level, and cardiovascular disease. Peritonitis is reported to cause death in 1 to 6% of PD patients but has not been well studied as a risk factor for mortality. This study examined 516 adults with a total of 896 yr on PD at one center to determine if peritonitis influenced mortality. Time at risk began on Day 1 of training and ended at death, transplant, or 60 days after transfer to hemodialysis or intermittent peritoneal dialysis. The overall mortality rate was 17.4/100 patient yr. Survival was lower for whites, men, diabetic patients, and older patients. Independent risk factors for mortality (by Cox proportional hazards) were race, diabetes, increased age, and increased peritonitis rate. Use of the Y-set was not associated with decreased mortality. Peritonitis was a risk factor only in whites, nondiabetic patients, and those patients over the age of 60. For every 0.5/yr increase in the peritonitis rate, the risk of death increased 10% in whites, 11% in those patients who were over the age of 60, and 4% for nondiabetic patients. Mortality rates did not decrease over time (1979 to 1995), although peritonitis rates fell significantly (P < 0.001). Rates of Gram-negative and fungal peritonitis showed no trend over time. Peritonitis contributed to 25 of 158 (15.8%) of deaths. Gram- negative/fungal peritonitis accounted for 14 deaths (9.5% of all Gram- negative/fungal episodes) whereas Staphylococcus epidermidis accounted for only 1 death (0.5% of all S. epidermidis episodes) (P < 0.001). Cardiovascular disease was more common in those patients whose deaths were unrelated to peritonitis (P < 0.01), whereas an infectious cause was more common in those patients whose deaths were peritonitis-related (P < 0.001). In this study, peritonitis was a risk factor for death in whites, nondiabetic patients, and older patients. However, the Y-set did not improve survival, perhaps because it does not decrease Gram- negative/fungal peritonitis. To have an impact on survival, efforts are needed to reduce the peritonitis that results from these more serious pathogens.

This article has been cited by other articles:

				C.-C. Szeto, B. C.-H. Kwan, K.-M. Chow, M.-F. Lau, M.-C. Law, K.-Y. Chung, C.-B. Leung, and P. K.-T. Li Coagulase Negative Staphylococcal Peritonitis in Peritoneal Dialysis Patients: Review of 232 Consecutive Cases Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 91 - 97. [Abstract] [Full Text] [PDF]

				J. Bernardini, F. Bender, T. Florio, J. Sloand, L. PalmMontalbano, L. Fried, and B. Piraino Randomized, Double-Blind Trial of Antibiotic Exit Site Cream for Prevention of Exit Site Infection in Peritoneal Dialysis Patients J. Am. Soc. Nephrol., February 1, 2005; 16(2): 539 - 545. [Abstract] [Full Text] [PDF]

				R. J Elwell, L. R Volino, and R. F Frye Stability of Cefepime in Icodextrin Peritoneal Dialysis Solution Ann. Pharmacother., December 1, 2004; 38(12): 2041 - 2044. [Abstract] [Full Text] [PDF]

				H. J Manley, R. J Elwell, G. R Bailie, and C. L Welch Intraperitoneal Cefazolin and Ceftazidime Effects on Human Peritoneal Mesothelial Cell Release of Cancer Antigen-125 Ann. Pharmacother., December 1, 2004; 38(12): 2035 - 2040. [Abstract] [Full Text] [PDF]

				C. Strijack, G. K. M. Harding, R. E. Ariano, and S. A. Zelenitsky Peritoneal Fluid Titer Test for Peritoneal Dialysis-Related Peritonitis Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1719 - 1726. [Abstract] [Full Text] [PDF]

				E. D. Hermsen, L. B. Hovde, J. R. Hotchkiss, and J. C. Rotschafer Increased Killing of Staphylococci and Streptococci by Daptomycin Compared with Cefazolin and Vancomycin in an In Vitro Peritoneal Dialysate Model Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3764 - 3767. [Abstract] [Full Text] [PDF]

				W. Van Biesen, N. Veys, R. Vanholder, and N. Lameire Peritoneal-dialysis-related peritonitis: the art of rope-dancing Nephrol. Dial. Transplant., November 1, 2002; 17(11): 1878 - 1882. [Full Text] [PDF]

				L. Piillips, S. J. Davies, and E. White Health-related quality of life assessment in end-stage renal failure Journal of Research in Nursing, May 1, 2001; 6(3): 658 - 670. [Abstract] [PDF]

				J.-W. Huang, T.-S. Chu, M.-S. Wu, Y.-S. Peng, and B.-S. Hsieh Visible Penicillium spp. colonization plaques on a Tenckhoff catheter without resultant peritonitis in a peritoneal dialysis patient Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1872 - 1873. [Full Text] [PDF]

				H. J. MANLEY, G. R. BAILIE, R. FRYE, L. D. HESS, and M. D. MCGOLDRICK Pharmacokinetics of Intermittent Intravenous Cefazolin and Tobramycin in Patients Treated with Automated Peritoneal Dialysis J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1310 - 1316. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673